Health and Happiness (H&H) International (OTCMKTS:BTSDF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Monday, Zacks.com reports. The firm currently has a $4.00 target price on the stock. Zacks Investment Research‘s target price would suggest a potential upside of 12.68% from the stock’s current price.
According to Zacks, “Health and Happiness International Holdings Limited manufactures and sells family nutrition and baby care products principally in Mainland China, Australia, New Zealand and internationally. Health and Happiness International Holdings Limited, formerly known as Biostime Pharmaceuticals Limited., is based in Quarry Bay, Hong Kong. “
Shares of BTSDF opened at $3.55 on Monday. Health and Happiness has a one year low of $3.55 and a one year high of $4.22. The stock’s fifty day moving average is $3.86 and its 200-day moving average is $4.00.
Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells family nutrition and baby care products worldwide. The company's Infant Formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers.
Recommended Story: What is a Candlestick Chart?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Health and Happiness (H&H) International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health and Happiness (H&H) International and related companies with MarketBeat.com's FREE daily email newsletter.